Development of a novel human recellularized endometrium that responds to a 28-day hormone treatment.
about
Development of a novel human recellularized endometrium that responds to a 28-day hormone treatment.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Development of a novel human r ...... to a 28-day hormone treatment.
@en
Development of a novel human r ...... to a 28-day hormone treatment.
@nl
type
label
Development of a novel human r ...... to a 28-day hormone treatment.
@en
Development of a novel human r ...... to a 28-day hormone treatment.
@nl
prefLabel
Development of a novel human r ...... to a 28-day hormone treatment.
@en
Development of a novel human r ...... to a 28-day hormone treatment.
@nl
P2093
P2860
P356
P1476
Development of a novel human r ...... to a 28-day hormone treatment.
@en
P2093
J Julie Kim
Joanna E Burdette
Spiro Getsios
Susan A Olalekan
P2860
P304
P356
10.1093/BIOLRE/IOX039
P407
P577
2017-05-01T00:00:00Z